What are the disadvantages of infusion pumps?
What are the disadvantages of infusion pumps?
Examples of Reported Infusion Pump Problems
- Software problems.
- Alarm errors.
- Inadequate user interface design (“human factors” issues)
- Broken components.
- Battery failures.
- Fire, sparks, charring, or shocks.
What are the drugs used in infusion pump?
They can deliver nutrients or medications, such as insulin or other hormones, antibiotics, chemotherapy drugs, and pain relievers. There are many types of infusion pumps, including large volume, patient-controlled analgesia (PCA), elastomeric, syringe, enteral, and insulin pumps,.
What happened Alaris pumps?
The recall impacts more than 145,000 pumps distributed in the U.S. CareFusion 303 Inc., a company owned by BD, issued the recall for the BD Alaris Infusion Pump Module Model 8100 on March 3 due to the risk of the keypad lifting up as a result of fluid entry.
What is the accuracy of infusion pumps?
Infusion pump user manuals typically report flow accuracy of +/-5%, but this is an average under controlled lab conditions. Actual pump performance in real-world conditions typically is less understood, despite the dramatic effect changing conditions can have on pump output and patient response.
What are the common causes of performance failure of infusion pumps?
The causes of these performance failures include, but are not limited to:
- Software defects.
- Inadequate user interface design (“human factors” issues)
- Damaged mechanical parts (e.g., doors and latches)
- Battery failures.
When did BD Buy Alaris?
CareFusion was a medical company specializing in two areas: reducing medication errors and prevention of health care-associated infections….CareFusion.
| Type | Subsidiary |
|---|---|
| Industry | Medical Technology |
| Founded | 2009 |
| Fate | Acquired by Becton Dickinson in 2015 |
| Successor | Becton Dickinson |
Who makes Alaris pumps?
Becton, Dickinson and Company (BD)
Becton, Dickinson and Company (BD) manufactures the BD Alaris Systems pumps. The U.S. Food and Drug Administration allowed the first models onto the market in the 1990s. The agency has since cleared more models for sale.